The Government must adopt the clawback tax bill and an order on the generic drugs, as per an agreement with the European Commission.
The clawback system was introduced in the fall of 2009 and required all drug producers selling on the Romanian market to contribute quarterly to the public healthcare system by 5%-11% of their revenue from the sale of products used by the national healthcare programs, included on the list of discounted/free medicine, or used in hospitals.
The Association of Romanian Producers of Generic Drugs has stated that the clawback tax is unfair, inefficient and ineffective.
Jeffrey Franks, head of the IMF agreement evaluation mission, has said the clawback tax should be replaced with a different taxation system.
(EUR1=RON4.2488)